Arbutus Biopharma Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Arbutus Biopharma Corp (ABUS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.56 million shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2019-03-07
- Arbutus Biopharma Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 2.56M shares, a 26.21% increase from fiscal 2017.
- Arbutus Biopharma Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 2.03M shares, a 13.24% increase from fiscal 2016.
- Arbutus Biopharma Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 1.79M shares, a 36.65% increase from fiscal 2015.
- Arbutus Biopharma Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 1.31M shares, a 203.77% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2018-12-31 | 2.56M shares 10-K · filed 2019-03-07 | ||
| 2017-12-31 | 2.03M shares 10-K · filed 2018-03-16 | ||
| 2016-12-31 | 1.79M shares 10-K · filed 2017-03-22 | ||
| 2015-12-31 | 1.31M shares 10-K · filed 2016-03-09 | ||
| 2015-03-25 | 1.13M shares 10-Q · filed 2015-11-05 | 1.13M shares 10-K · filed 2018-03-16 | |
| 2014-12-31 | 431.13K shares 10-K · filed 2015-03-13 | ||
| 2013-12-31 | 270.25K shares 10-K · filed 2015-03-13 | ||
| 2012-12-31 | 326.30K shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |